Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, 430030 Wuhan, China.
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, 430030 Wuhan, China.
Biomed Res Int. 2022 Jul 28;2022:4436646. doi: 10.1155/2022/4436646. eCollection 2022.
To conduct a comprehensive bioinformatics analysis on the transcriptome signatures of Toll-like receptors (TLRs) in pan-cancer. . A total of 11,057 tissues consisting of 33 types of carcinoma in The Cancer Genome Atlas (TCGA) were retrieved, and then we further explored the correlation between TLRs' expression with tumorigenesis, immune infiltration, and drug sensitivity. We conducted a comprehensive bioinformatics analysis on TLR1 to 10 in pan-cancer, including differential expression analysis between normal and tumor tissues, differential immune subtype correlation, survival analysis, tumor immune infiltration estimating, stemness indices correlation, and drug responses correlation.
TLR2 was highly expressed in most types of tumors. TLR9 was hardly expressed compared to other TLR genes, which lead to TLR9 showing less correlation with both immune-estimate scores and stromal-estimate scores. All the TLRs were related with immune subtype of tumor samples that all of them were differentially expressed in differential immune subtype samples. The expression of TLRs was positively related with immune-estimate scores and stromal-estimate scores in almost all types of tumor. The expression of TLRs was negatively correlated with mRNA expression-based stemness scores (RNAss) in nearly almost type of tumors except kidney renal clear cell carcinoma (KIRC) and also negatively correlated with DNA methylation-based stemness scores (DNAss) in many types of tumors except adrenocortical carcinoma (ACC), cholangiocarcinoma (CHOL), KIRC, acute myeloid leukemia (LAML), low-grade glioma (LGG), testicular germ cell tumors (TGCT), thyroid carcinoma (THCA), thymoma (THYM), and uveal melanoma (UVM). The expression of TLR9 was significantly positively correlated with the drug sensitivity of fluphenazine, alectinib, carmustine, and 7-hydroxystaurosporine. TLR7 was significantly positively correlated with the drug sensitivity of alectinib.
Our study reveals the significant role of TLRs family in pan-cancer and provides potential therapeutic strategies of cancer.
对泛癌种中的 Toll 样受体(TLR)转录组特征进行全面的生物信息学分析。从癌症基因组图谱(TCGA)中检索到了 11057 个组织,包括 33 种癌,然后我们进一步探讨了 TLR 表达与肿瘤发生、免疫浸润和药物敏感性的相关性。我们对泛癌种中的 TLR1 到 TLR10 进行了全面的生物信息学分析,包括正常组织和肿瘤组织之间的差异表达分析、差异免疫亚型相关性、生存分析、肿瘤免疫浸润评估、干性指数相关性和药物反应相关性。
TLR2 在大多数类型的肿瘤中高表达。与其他 TLR 基因相比,TLR9 的表达水平较低,这导致 TLR9 与免疫估计评分和基质估计评分的相关性都较小。所有 TLR 都与肿瘤样本的免疫亚型相关,它们在差异免疫亚型样本中都有差异表达。TLR 的表达与几乎所有类型肿瘤的免疫估计评分和基质估计评分呈正相关。除肾透明细胞癌(KIRC)外,TLR 的表达与基于 mRNA 的干性评分(RNAss)呈负相关,除肾上腺皮质癌(ACC)、胆管癌(CHOL)、KIRC、急性髓系白血病(LAML)、低级别胶质瘤(LGG)、睾丸生殖细胞肿瘤(TGCT)、甲状腺癌(THCA)、胸腺瘤(THYM)和葡萄膜黑色素瘤(UVM)外,TLR 的表达与基于 DNA 甲基化的干性评分(DNAss)也呈负相关。TLR9 的表达与氟奋乃静、阿来替尼、卡莫司汀和 7-羟基星形孢菌素的药物敏感性显著正相关。TLR7 与阿来替尼的药物敏感性显著正相关。
我们的研究揭示了 TLR 家族在泛癌中的重要作用,并为癌症的潜在治疗策略提供了依据。